【2h】

Thyroid Function and Obesity

机译:甲状腺功能与肥胖

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Important interaction exists between thyroid function, weight control, and obesity. Several mechanisms seem to be involved, and in studies of groups of people the pattern of thyroid function tests depends on the balance of obesity and underlying thyroid disease in the cohort studied. Obese people with a normal thyroid gland tend to have activation of the hypothalamic-pituitary-thyroid axis with higher serum TSH and thyroid hormones in serum. On the other hand, small differences in thyroid function are associated with up to 5 kg difference in body weight. The weight loss after therapy of overt hypothyroidism is caused by excretion of water bound in tissues (myxoedema). Many patients treated for hyperthyroidism experience a gain of more weight than they lost during the active phase of the disease. The mechanism for this excessive weight gain has not been fully elucidated. New studies on the relation between L-T3 therapy and weight control are discussed. The interaction between weight control and therapy of thyroid disease is important to many patients and it should be studied in more detail.
机译:甲状腺功能,体重控制和肥胖之间存在重要的相互作用。似乎涉及几种机制,在人群研究中,甲状腺功能测试的模式取决于所研究人群中肥胖与潜在甲状腺疾病的平衡。患有正常甲状腺的肥胖者倾向于激活下丘脑-垂体-甲状腺轴,并具有较高的血清TSH和血清中的甲状腺激素。另一方面,甲状腺功能的细微差异与体重差异最大5公斤有关。明显的甲状腺功能减退症治疗后的体重减轻是由组织内结合水的排泄引起的(粘液水肿)。在甲状腺机能亢进症中,许多接受甲状腺机能亢进治疗的患者体重增加超过其活跃阶段所减轻的体重。这种过度增加体重的机制尚未完全阐明。讨论了有关L-T3治疗与体重控制之间关系的新研究。体重控制与甲状腺疾病治疗之间的相互作用对许多患者而言很重要,应进行更详细的研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号